文献速递免疫规划

健康出生队列中两种免疫程序接种十价肺炎球菌结合疫苗后的唾液抗体应答

Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.
PubMed 文献 · Vaccine · 2021-12-24

荷兰2013年将婴儿十价肺炎球菌结合疫苗(PCV10)程序从3+1(2-3-4-11月龄)改为2+1(2-4-11月龄)。本研究比较两种程序接种后6月龄(基础免疫后)和12月龄(加强免疫后)唾液抗肺炎球菌IgG浓度,发现基础免疫后各疫苗血清型IgG几何平均浓度(GMC)相当,加强免疫后2+1程序对血清型4(p=0.035)、7F(p=0.048)和23F(p=0.0056)的IgG GMC显著较低。

要点

  • 基础免疫后两种程序所有疫苗血清型唾液IgG GMC相当。
  • 加强免疫后2+1程序血清型4、7F、23F的IgG GMC显著低于3+1程序。
  • 未来研究应建立黏膜抗体对肺炎球菌定植的保护相关性。

核心结论

  • 3+1与2+1 PCV10程序间的黏膜IgG应答存在小差异,加强免疫后2+1程序对血清型4、7F和23F的唾液IgG GMC显著较低。

研究设计与样本

  • 研究比较荷兰2013年更改的PCV10 3+1程序(2-3-4-11月龄)与2+1程序(2-4-11月龄)接种后唾液抗肺炎球菌IgG浓度。
  • 纳入51名接受3+1程序的婴儿和68名接受2+1程序的婴儿,在6月龄(基础免疫后)和12月龄(加强免疫后)用荧光微球多重免疫分析法检测IgG。

主要发现

  • 基础免疫后,两种程序所有疫苗血清型的唾液IgG GMC相当。
  • 加强免疫后,2+1程序血清型4的IgG GMC显著低于3+1程序(p=0.035)。
  • 加强免疫后,2+1程序血清型7F的IgG GMC显著低于3+1程序(p=0.048)。
  • 加强免疫后,2+1程序血清型23F的IgG GMC显著低于3+1程序(p=0.0056)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来研究应建立黏膜抗体对肺炎球菌定植的保护相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pneumococcal conjugate vaccines reduce pneumococcal colonization via serotype-specific immunoglobulin G (IgG) at mucosal surfaces. The infant immunization schedule with the ten-valent pneumococcal conjugate vaccine (PCV10) changed from a 3 + 1 schedule (2-3-4-11 months) to a 2 + 1 schedule (2-4-11 months) in The Netherlands in 2013. We compared anti-pneumococcal IgG concentrations in saliva between the schedules. IgG was measured using a fluorescent bead-based multiplex immunoassay at the ages of 6 (post-primary) and 12 (post-booster) months in 51 infants receiving the 3 + 1 schedule and 68 infants receiving the 2 + 1 schedule. Post-primary IgG geometric mean concentrations (GMCs) were comparable between schedules for all vaccine serotypes. Post-booster IgG GMCs were significantly lower after the 2 + 1 schedule for serotypes 4 (p = 0.035), 7F (p = 0.048) and 23F (p = 0.0056). This study shows small differences in mucosal IgG responses between a 3 + 1 and a 2 + 1 PCV10 schedule. Future studies should establish correlates of protection against pneumococcal colonization for mucosal antibodies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. de Koff EM, van Houten MA, de Heij F, et al. Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort. Vaccine. 2021. PMID: 34961634. doi:10.1016/j.vaccine.2021.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。